The study participants with the AD resilience phenotype died at an older age (mean age, 88.3 vs. 82.4 years), were more often women (61.3% vs. 47.3%), and had a lower prevalence of APOE-e4 (41.9% vs. 56.2%) and a lower proportion of CERAD and Braak VI stage, compared to those without resilience (Table 1). The gene discussed is APOE; the disease is Alzheimer disease.